Last reviewed · How we verify
Combination Chemotherapy in Treating Patients With Lymphoma
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Randomized phase III trial to compare the effectiveness of two regimens of combination chemotherapy in treating patients who have intermediate-grade or immunoblastic lymphoma.
Details
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 116 |
| Start date | Mon Oct 30 1995 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Feb 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Lymphoma
Interventions
- Bleomycin Sulfate (BLM)
- Filgrastim (G-CSF)
- Recombinant Interferon Alfa
- Carmustine
- Cisplatin (CDDP)
- Cyclophosphamide
- Cytarabine (ARA-C)
- Etoposide (VP-16)
- Idarubicin
- Ifosfamide
Countries
United States